- HOME
- Proposals/News
- Policy advocacy
Proposals/News / Policy advocacy
- Policy advocacy
- Advocacy
2026.02.05【Public Consultation】Submission of Comments on the Draft Cabinet Order and Related Ordinances for the Amendment of the Payment Services Act- Policy advocacy
- Advocacy
2026.02.05【Public Consultation】Submission of Comments on the MIC’s Draft “Guidelines on Technical Measures for Ensuring AI Security”- Policy advocacy
- Advocacy
2026.01.27【Public Consultation】Submission of Comments on the Cabinet Office’s Draft “Principles and Code on the Protection of Intellectual Property and Transparency for the Appropriate Use of Generative AI (provisional title)”- AI
- Representative Director
- Press Release
- Policy advocacy
- Advocacy
2026.01.27A Statement by JANE Representative Director Mickey Mikitani on the Public Notice of the House of Representatives Election- Policy advocacy
- Advocacy
2025.12.19【Public Consultation】Submission of Comments on the “Draft Outline of the AI Outline of the AI Basic Plan and the Draft Outline of Guidelines for Ensuring the Appropriateness of Research, Development and Utilization of AI-Related Technologies”- AI
- Policy advocacy
- Advocacy
2025.12.19【Public Consultation】Submission of Comments on the “Draft Guidelines for Ensuring the Appropriateness of Research & Development and Utilization of AI-Related Technologies”- AI
- Policy advocacy
- Advocacy
2025.12.16【Public Consultation】Submission of Comments on the “Draft Pharmaceuticals designated by the Minister of MHLW based pursuant to Article 36-11, Paragraph 1 of the PMD Act and the “Draft Quantities determined by Minister of MHLW pursuant to Article 159-18-6, Paragraph 1 of the Ordinance for Enforcement of the PMD Act by the MHLW- Representative Director
- Policy advocacy
- Advocacy
2025.12.08Comment: Submitted Comments at the 11th Digital Society Initiative Conference, Digital Agency- Event/Seminar
- Policy advocacy
- Advocacy
2025.11.07Event Report: JX Live! 2025- Policy advocacy
- Advocacy
2025.11.04【Public Consultation】Submission of Comments on the Ministry of Health, Labour and Welfare’s “Draft Ministerial Ordinance for the Development of Related Ministerial Ordinances in conjunction with the Enforcement of Part of the Act for Partial Revision of the Act on Securing Quality, Efficacy and Safety of Products Including Pharmaceuticals and Medical Devices, etc.”
Proposals/News
